Literature DB >> 17434248

Chagas disease in Texas: recognizing the significance and implications of evidence in the literature.

Elaine Jennifer Hanford1, F Benjamin Zhan, Yongmei Lu, Alberto Giordano.   

Abstract

Chagas disease is endemic and is recognized as a major health problem in many Latin American countries. Despite the parallels between socio-economic and environmental conditions in Texas and much of Latin America, Chagas disease is not a notifiable human disease in Texas. Based on extensive review of related literature, this paper seeks to recognize the evidence that Chagas Disease is endemic to Texas but the epidemiological, parasitological and entomological patterns of Chagas disease in Texas are both different from and parallel to other endemic regions. We find that with a growing immigrant human reservoir, the epidemiological differences may be reduced and result in increasing incidence of the disease. Chagas disease should be recognized as an emerging disease among both immigrant and indigenous populations. Without proper actions, Chagas disease will place increasing burden on the health care system. Current medical treatments consist of chemotherapies that carry the risk of serious side effects; curing the potentially fatal disease remains equivocal. Therefore, as shown in South America, prevention is paramount and can be successfully achieved through intervention and education. We conclude that biogeographical research is needed to (1) distinguish the dynamic evolution of the agent-vector-host system, (2) document locations with greater risk and identify mechanisms responsible for observed changes in risk, and (3) assist in developing a model for Triatomid vector-borne disease in states like Texas where the disease is both endemic and may be carried by a sizeable immigrant population. Tracking of Chagas disease and planning for appropriate health care services would also be aided by including Chagas disease on the list of reportable diseases for humans.

Entities:  

Mesh:

Year:  2007        PMID: 17434248     DOI: 10.1016/j.socscimed.2007.02.041

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  24 in total

1.  High Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae) prevalence in Triatoma sanguisuga (Hemiptera: Redviidae) in southeastern Louisiana.

Authors:  K Cesa; K A Caillouët; P L Dorn; D M Wesson
Journal:  J Med Entomol       Date:  2011-09       Impact factor: 2.278

2.  Natural Chagas disease in four baboons.

Authors:  Jeff T Williams; Edward J Dick; John L VandeBerg; Gene B Hubbard
Journal:  J Med Primatol       Date:  2008-07-30       Impact factor: 0.667

3.  Polymerase chain reaction detection of Trypanosoma cruzi in Macaca fascicularis using archived tissues.

Authors:  Jeff T Williams; James N Mubiru; Natalia E Schlabritz-Loutsevitch; Rohina C Rubicz; John L VandeBerg; Edward J Dick; Gene B Hubbard
Journal:  Am J Trop Med Hyg       Date:  2009-08       Impact factor: 2.345

4.  The Prevalence of Trypanosoma cruzi, the Causal Agent of Chagas Disease, in Texas Rodent Populations.

Authors:  Adriana Aleman; Trina Guerra; Troy J Maikis; Matthew T Milholland; Ivan Castro-Arellano; Michael R J Forstner; Dittmar Hahn
Journal:  Ecohealth       Date:  2017-01-13       Impact factor: 3.184

5.  Antitrypanosomal activities and cytotoxicity of some novel imido-substituted 1,4-naphthoquinone derivatives.

Authors:  Mozna H Khraiwesh; Clarence M Lee; Yakini Brandy; Emmanuel S Akinboye; Solomon Berhe; Genelle Gittens; Muneer M Abbas; Franklin R Ampy; Mohammad Ashraf; Oladapo Bakare
Journal:  Arch Pharm Res       Date:  2012-02-02       Impact factor: 4.946

Review 6.  Design or screening of drugs for the treatment of Chagas disease: what shows the most promise?

Authors:  Galina I Lepesheva
Journal:  Expert Opin Drug Discov       Date:  2013-09-30       Impact factor: 6.098

7.  Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.

Authors:  F H Guedes-da-Silva; D G J Batista; C F Da Silva; J S De Araújo; B P Pavão; M R Simões-Silva; M M Batista; K C Demarque; O C Moreira; C Britto; G I Lepesheva; M N C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

8.  Using museum collections to detect pathogens.

Authors:  C Miguel Pinto; B Dnate Baxter; J Delton Hanson; Francisca M Mendez-Harclerode; John R Suchecki; Mario J Grijalva; Charles F Fulhorst; Robert D Bradley
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

9.  Chagas disease risk in Texas.

Authors:  Sahotra Sarkar; Stavana E Strutz; David M Frank; Chissa-Louise Rivaldi; Blake Sissel; Victor Sánchez-Cordero
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

10.  Sequence variation in CYP51A from the Y strain of Trypanosoma cruzi alters its sensitivity to inhibition.

Authors:  Tatiana S Cherkesova; Tatiana Y Hargrove; M Cristina Vanrell; Igor Ges; Sergey A Usanov; Patricia S Romano; Galina I Lepesheva
Journal:  FEBS Lett       Date:  2014-09-12       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.